[cmsmasters_row data_padding_bottom=”50″ data_padding_top=”0″ data_bg_parallax_ratio=”0.5″ data_bg_size=”cover” data_bg_attachment=”scroll” data_bg_repeat=”no-repeat” data_bg_position=”top center” data_color=”default” data_bot_style=”default” data_top_style=”default” data_padding_right=”3″ data_padding_left=”3″ data_width=”boxed”][cmsmasters_column data_width=”1/1″][cmsmasters_text animation_delay=”0″]

J Matern Fetal Neonatal Med. 2019 Jul 1:1-9. doi: 10.1080/14767058.2019.1635112. [Epub ahead of print]

Hepcidin as a diagnostic biomarker of iron deficiency anemia during pregnancy

Zaman B¹, Rasool S², Jasim S³, Abdulah D⁴.

^{1a Department of Pharmacology and Clinical Pharmacy, College of Pharmacy, University of Duhok , Duhok City , Iraq.}

^{2b Department of Pharmaceutics, College of Pharmacy , University of Duhok , Duhok City , Iraq.}

^{3c Department of Obstetrics and Gynecology , Alkansaa Teaching Hospital , Mosul , Iraq.}

^{4d Adult Nursing Department, College of Nursing , University of Duhok , Duhok City , Iraq.}

Abstract

Objectives: Hepcidin hormone production is suppressed in the case of iron deficiency. The role of hepcidin as a hormone in iron metabolism along with its diagnostic cut-off values and its sensitivity and specificity among pregnant women with iron deficiency anemia (IDA) was examined in this study.

Methods: In this case-control study, three groups of pregnant subjects were included according to the following criteria: cases/patient group: pregnant women with IDA based on, Hb < 11.5 g/dl, S ferritin < 10 ng/ml, TS%<15%; positive control group: pregnant women with non-IDA based on, Hb < 11.5 g/dl, S ferritin > 10 ng/ml, TS%>15%; and negative control group: included non-anemic apparently healthy pregnant women based on, Hb > 11.5 g/dl, S ferritin > 10 ng/ml, TS%>15%.

Results: The serum hepcidin was significantly lower in pregnant women with IDA (0.34 ng/ml) compared to its level in pregnant women with non-IDA (23.48 ng/l) and apparently healthy pregnant women (13.86 ng/ml; p<.001). The study found a significant correlation between serum hepcidin and iron deficiency-related parameters with adjustment for study groups (p<.01). Moreover, the study found that serum hepcidin has good sensitivity in the range of 0.49-0.76 ng/ml (80.6-83.3%) and good specificity (76.2%) over positive IDA. Similar results were found for serum hepcidin over negative control group (0.49-0.83 ng/ml; sensitivity: 80.6-83.3%; specificity: 75.8-78.8%).

Conclusions: This study suggests that serum hepcidin is superior to hemoglobin, serum iron, serum ferritin, TS, and TIBC as an indicator of IDA in pregnant women.

KEYWORDS: Hepcidin; iron deficiency anemia; pregnancy

[/cmsmasters_text][cmsmasters_button button_type=”regular” button_link=”https://www.tandfonline.com/doi/full/10.1080/14767058.2019.1635112?scroll=top&needAccess=true” button_target=”blank” button_text_align=”left” button_style=”cmsmasters_but_bg_slide_left” button_font_weight=”normal” button_font_style=”normal” button_border_style=”solid” animation_delay=”0″]The Journal of Maternal-Fetal & Neonatal Medicine[/cmsmasters_button][cmsmasters_text animation_delay=”0″]
[/cmsmasters_text][/cmsmasters_column][/cmsmasters_row]